Kesatuan Eropah - Denmark - EMA (European Medicines Agency)

mylan s.a.s - ambrisentan - hypertension, lunge - antihypertensiva, - ambrisentan mylan er indiceret til behandling af pulmonal arteriel hypertension (pah) hos voksne patienter, som funktionel class (fc) ii til iii, herunder til brug i kombination behandling. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah associeret med bindevævssygdom. ambrisentan mylan er indiceret til behandling af pulmonal arteriel hypertension (pah) hos voksne patienter, som funktionel class (fc) ii til iii, herunder til brug i kombination behandling. effektivitet er blevet vist i idiopatisk pah (ipah) og i pah associeret med bindevævssygdom.

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - ambrisentan - filmovertrukne tabletter - 5 mg

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

aop orphan pharmaceuticals gmbh - ambrisentan - filmovertrukne tabletter - 5 mg

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - ambrisentan - filmovertrukne tabletter - 5 mg

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

sandoz a/s - ambrisentan - filmovertrukne tabletter - 5 mg

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

accord healthcare b.v. - ambrisentan - filmovertrukne tabletter - 10 mg

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

pharma nord aps - selenoprecise yeast - depottabletter - 100 mikrogram

Denmark - Denmark - Lægemiddelstyrelsen (Danish Medicines Agency)

teva b.v. - ambrisentan - filmovertrukne tabletter - 10 mg

Kesatuan Eropah - Denmark - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenzavirusoverfladeantigener (hæmagglutinin og neuraminidase) af stamme a / viet nam / 1194/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vacciner - aktiv immunisering mod h5n1-subtype af influenza a-virus. , , this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain. , , prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Kesatuan Eropah - Denmark - EMA (European Medicines Agency)

ceva-phylaxia veterinary biologicals co. ltd - turkey herpes virus, strain rhvt/nd/ibd, expressing the fusion protein of newcastle disease virus and the vp2 protein of infectious bursal disease virus, live recombinant - immunologicals for aves - embryonated chicken eggs; chicken - for the active immunisation of one-day-old chicks or 18-day-old chicken embryonated eggs to reduce mortality, clinical signs and lesions caused by newcastle disease virus (ndv) and to reduce virus shedding; to reduce mortality, clinical signs and bursa lesions caused by very virulent infectious bursal disease virus (ibdv); to reduce mortality, clinical signs and lesions caused by classical marek’s disease virus (mdv).